Integration of high-risk human papillomavirus DNA correlates with HLA genotype aberration and reduced HLA class I molecule expression in human cervical carcinoma

Clinical Immunology

Volumn 115, Issue 3, 2005, Pages 295-301

  Sheu, Bor Ching ^a   Chiou, Shin Heng ^b   Chang, Wen Chun ^a   Chow, Song Nan ^a   Lin, Ho Hsiung ^a   Chen, Ruey Jien ^a   Huang, Su Cheng ^a   Ho, Hong Nerng ^a,b   Hsu, Su Ming ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Cancer; DNA; Genotype; HLA; Human papilloma virus; Mutation

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN; VIRUS DNA;

ANTIGEN EXPRESSION; ARTICLE; CANCER GENETICS; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; FEMALE; GENE DISRUPTION; GENE LOCUS; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HLA SYSTEM; HUMAN; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; SOUTHERN BLOTTING; TUMOR IMMUNITY; TUMOR PROMOTION; UTERINE CERVIX CARCINOMA; VIRUS VIRULENCE; WART VIRUS;

CARCINOMA; DNA, VIRAL; DOWN-REGULATION; FEMALE; GENES, MHC CLASS I; HLA ANTIGENS; HUMANS; MUTATION; PAPILLOMAVIRIDAE; PHENOTYPE; UTERINE CERVICAL NEOPLASMS; VIRUS INTEGRATION;

EID: 19044380197     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2005.02.001     Document Type: Article

References (40)

1. F. Lehmann, M. Marchand, P. Hainaut, P. Pouillart, X. Sastre, H. Ikeda, T. Boon, and P.G. Coulie Differences in the antigens recognised by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection Eur. J. Immunol. 25 1995 340 347
2. F. Garrido, F. Ruiz-Cabello, T. Cabrera, J.J. Perez-Villar, M. Lopez-Botet, M. Duggan-Keen, and P.L. Stern Implications for immunosurveillance of altered HLA class I phenotypes in human tumours Immunol. Today 18 1997 89 95
3. F. Ruiz-Cabello, and F. Garrido HLA and cancer: from research to clinical impact Immunol. Today 19 1998 539 542
4. L.A. Koopman, A.R. van Der Slik, M.J. Giphart, and G.J. Fleuren Human leukocyte antigen class I gene mutations in cervical cancer J. Natl. Cancer Inst. 91 1999 1669 1677
5. T. Cabrera, M. Angustias Fernandez, A. Sierra, A. Garrido, A. Herruzo, A. Escobedo, A. Fabra, and F. Garrido High frequency of altered HLA class I phenotypes in invasive breast carcinomas Hum. Immunol. 50 1996 127 134
6. T. Cabrera, A. Collado, M.A. Fernandez, A. Ferron, J. Sancho, F. Ruiz-Cabello, and F. Garrido High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas Tissue Antigens 52 1998 114 123
7. L.A. Koopman, A. Mulder, W.E. Corver, J.D. Anholts, M.J. Giphart, F.H. Claas, and G.J. Fleuren HLA class I phenotype and genotype alterations in cervical carcinomas and derivative cell lines Tissue Antigens 51 1998 623 636
8. L.A. Koopman, W.E. Corver, A.R. van der Slik, M.J. Giphart, and G.J. Fleuren Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer J. Exp. Med. 191 2000 961 976
9. C.S. Brady, J.S. Bartholomew, D.J. Burt, M.F. Duggan-Keen, S. Glenville, N. Telford, A.M. Little, J.A. Davidson, P. Jimenez, F. Ruiz-Cabello, F. Garrido, and P.L. Stern Multiple mechanisms underlie HLA dysregulation in cervical cancer Tissue Antigen 55 2000 401 411
10. B.C. Sheu, R.H. Lin, H.N. Ho, and S.C. Huang Down-regulation of CD25 expression on activated tumor-infiltrating lymphocytes derived from human cervical carcinoma Hum. Immunol. 56 1997 39 48
11. B.C. Sheu, S.M. Hsu, H.N. Ho, R.H. Lin, P.L. Torng, and S.C. Huang Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes correlate with disease progression in human cervical cancer Cancer 86 1999 1537 1543
12. B.C. Sheu, R.H. Lin, H.C. Lien, H.N. Ho, S.M. Hsu, and S.C. Huang Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer J. Immunol. 167 2001 2972 2978
13. B.C. Sheu, S.M. Hsu, H.N. Ho, H.C. Lien, S.C. Huang, and R.H. Lin A novel role of metalloproteinase in cancer-mediated immunosuppression Cancer Res. 61 2001 237 242
14. B.C. Sheu, H.C. Lien, H.N. Ho, H.H. Lin, S.N. Chow, S.C. Huang, and S.M. Hsu Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer Cancer Res. 63 2003 6537 6542
15. J.M. Walboomers, M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, K.V. Shah, P.J. Snijders, J. Peto, C.J. Meijer, and N. Munoz Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J. Pathol. 189 1999 12 19
16. B. Kleter, L.J. van Doorn, J. ter Schegget, L. Schrauwen, K. van Krimpen, M. Burger, B. ter Harmsel, and W. Quint Technical advance: novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses Am. J. Pathol. 153 1998 1731 1739
17. M.E. Connor, and P.L. Stern Loss of MHC class-I expression in cervical carcinomas Int. J. Cancer 46 1990 1029 1034
18. C.G. Hilders, J.G. Houbiers, E.J. Krul, and G.J. Fleuren The expression of histocompatibility-related leukocyte antigens in the pathway to cervical carcinoma Am. J. Clin. Pathol. 101 1994 5 12
19. C.G. Hilders, I.M. Munoz, Y. Nooyen, and G.J. Fleuren Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance Gynocol. Oncol. 57 1995 366 375
20. V. Levitsky, Q.J. Zhang, J. Levitskaya, and M.G. Masucci The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4 J. Exp. Med. 183 1996 915 926
21. B. Seliger, A. Hohne, A. Knuth, H. Bernhard, T. Meyer, R. Tampe, F. Momburg, and C. Huber Analysis of the major histocompatibility complex class I antigen presentation machinery in normal and malignant renal cells: evidence for deficiencies associated with transformation and progression Cancer Res. 56 1996 1756 1760
22. K. Delp, F. Momburg, C. Hilmes, C. Huber, and B. Seliger Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin Bone Marrow Transplant. 25 2000 S88 S95
23. U. Ritz, F. Momburg, H. Pilch, C. Huber, M.J. Maeurer, and B. Seliger Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma Int. J. Oncol. 19 2001 1211 1220
24. A. Garcia-Lora, I. Algarra, J.J. Gaforio, F. Ruiz-Cabello, and F. Garrido Immunoselection by T lymphocytes generates repeated MHC class I-deficient metastatic tumor variants Int. J. Cancer 91 2000 109 119
25. G.L. Palmisano, M.P. Pistillo, P. Capanni, C. Pera, G. Nicolo, S. Salvi, L. Perdelli, G. Pasciucco, and G.B. Ferrara Investigation of HLA class I downregulation in breast cancer by RT-PCR Hum. Immunol. 62 2001 133 139
26. H. Ikeda, B. Lethe, F. Lehmann, N. van Baren, J.F. Baurain, C. de Smet, H. Chambost, M. Vitale, A. Moretta, T. Boon, and P.G. Coulie Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor Immunity 6 1997 199 208
27. C. Cordon-Cardo, Z. Fuks, M. Drobnjak, C. Moreno, L. Eisenbach, and M. Feldman Expression of HLA-A, B, C antigens on primary and metastatic tumor cell populations of human carcinomas Cancer Res. 51 1991 6372 6380
28. T. Kageshita, S. Hirai, T. Ono, D.J. Hicklin, and S. Ferrone Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression Am. J. Pathol. 154 1999 745 754
29. F.V. Cromme, P.F. van Bommel, J.M. Walboomers, M.P. Gallee, P.L. Stern, P. Kenemans, T.J. Helmerhorst, M.J. Stukart, and C.J. Meijer Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours Br. J. Cancer 69 1994 1176 1181
30. M. Perez, I. Algarra, H.G. Ljunggren, A. Caballero, M.J. Mialdea, J.J. Gaforio, G. Klein, K. Karre, and F. Garrido A weakly tumorigenic phenotype with high MHC class-I expression is associated with high metastatic potential after surgical removal of the primary murine fibrosarcoma Int. J. Cancer 46 1990 258 261
31. H.M. Lee, T.L. Timme, and T.C. Thompson Resistance to lysis by cytotoxic T cells: a dominant effect in metastatic mouse prostate cancer cells Cancer Res. 60 2000 1927 1933
32. D.J. Nelson, S. Mukherjee, C. Bundell, S. Fisher, D. van Hagen, and B. Robinson Tumor progression despite efficient tumor antigen cross-presentation and effective "arming" of tumor antigen-specific CTL J. Immunol. 166 2001 5557 5566
33. M.K. Kang, and N.H. Park Conversion of normal to malignant phenotype: telomere shortening, telomerase activation, and genomic instability during immortalization of human oral keratinocytes Crit. Rev. Oral Biol. Med. 12 2001 38 54
34. A. Cottage, S. Dowen, I. Roberts, M. Pett, N. Coleman, and M. Stanley Early genetic events in HPV immortalized keratinocytes Genes Chromosomes Caner 30 2001 72 79
35. P. Peitsaro, B. Johansson, and S. Syrjanen Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique J. Clin. Microbiol. 40 2002 886 891
36. M. Kalantari, E. Blennow, B. Hagmar, and B. Johansson Physical state of HPV16 and chromosomal mapping of the integrated form in cervical carcinomas Diagn. Mol. Pathol. 10 2001 46 54
37. P. Peitsaro, S. Hietanen, B. Johansson, T. Lakkala, and S. Syrjanen Single copy heterozygote integration of HPV 33 in chromosomal band 5p14 is found in an epithelial cell clone with selective growth advantage Carcinogenesis 23 2002 1057 1064
38. A.A. Brink, J.C. Wiegant, K. Szuhai, H.J. Tanke, G.G. Kenter, G.J. Fleuren, E. Schuuring, and A.K. Raap Simultaneous mapping of human papillomavirus integration sites and molecular karyotyping in short-term cultures of cervical carcinomas by using 49-color combined binary ratio labeling fluorescence in situ hybridization Cancer Genet. Cytogenet. 134 2002 145 150
39. M.H. Einstein, Y. Cruz, M.K. El-Awady, N.C. Popescu, J.A. DiPaolo, M. van Ranst, A.S. Kadish, S. Romney, C.D. Runowicz, and R.D. Burk Utilization of the human genome sequence localizes human papillomavirus type 16 DNA integrated into the TNFAIP2 gene in a fatal cervical cancer from a 39-year-old woman Clin. Cancer Res. 8 2002 549 554
40. J.S. Bartholomew, S. Glenville, S. Sarkar, D.J. Burt, M.A. Stanley, F. Ruiz-Cabello, J. Chengang, F. Garrido, and P.L. Stern Integration of high-risk human papillomavirus DNA is linked to the down-regulation of class I human leukocyte antigens by steroid hormones in cervical tumor cells Cancer Res. 57 1997 937 942